Tarsus Pharmaceuticals is expanding its pipeline to target meibomian gland disease and rosacea, with promising Phase 2 ...

Beyond MariTide, Amgen has a rich pipeline with more than 30 phase 3 programs. Some are for existing medicines seeking label ...

According to US secondary stroke prevention guidelines, patients with ESUS should not be treated with anticoagulants or ...

IDEAYA Biosciences is a promising biotech company targeting genetic vulnerabilities in cancer cells with synthetic lethality.

The surge in global cancer cases is raising serious concerns among experts. A recent study published in Monday in Cancer, a ...

Shares of Amgen Inc. AMGN inched 0.91% higher to $335.95 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 1.70% to 5,713.64 ...

“I’m right in the mix,” claimed McIlroy, the world number three, after posting a second round 68 – five birdies and one lone ...

Bob MacIntyre reckoned it was a case of “robbery” as he shot the “best two-under-par round of my life” to be in the mix along ...

This Comment is linked to The Lancet Haematology Series on Sexual Health in Patients with Haematological Malignancies; we ...

Tourism Northern Ireland has described the recent Amgen Irish Open in Co Down as “incredibly successful”. More than 71,000 ...

The US stock markets opened lower on Friday, September 20, as investors held back after a jump in the previous session, which ...

Two specialists are impressed by the preliminary findings of a randomized trial in newly diagnosed patients, but another is ...